The majority of the MDSCs in glioblastoma patients were CD15+CD14− PMN-MDSCs (82%), followed by lineage-negative e-MDSCs (15%) and M-MDSCs (3%) [20]. This evidence concerns the gene FUT4 and glioblastoma.